Converge Biotech


Converge Biotech, established in 2015 and based in Hyderabad, Telangana, is committed to delivering quality medicines at economical prices, especially in the chronic care sector. The company aims to make high-quality and affordable medicines accessible globally, fostering innovation and building trust among stakeholders. With a diversified portfolio and a focus on patient welfare, Converge Biotech is expanding its presence both in India and internationally, emphasizing research, education, and strategic collaborations.

Industries

biotechnology
health-care
medical
pharmaceutical

Nr. of Employees

medium (51-250)

Converge Biotech

7-2-1735&7-2-1813/5 ,2nd &3rd Floor, PLOT NO:03 STREET NO:1 CZECH COLONY, SANATH NAGAR, HYDERABAD- 500018, TELANGANA.


Patents

Therapeutic hybrid implantable devices

US-8702684-B2

View Details

Products

Branded pharmaceutical product portfolio (Critical Care, Metabolics, Specialty, Oncology)

A portfolio of branded formulations spanning critical care (anti-infectives and supportive care), metabolics (diabetes, hypertension, weight management), specialty (nephrology and urology), and precision oncology-related offerings.


Services

Supply, distribution, and account management for pharmaceutical products to hospitals and institutional customers.

Management and coordination of contract manufacturing arrangements to support product supply.

Campaigns and educational initiatives for patients and caregivers focusing on disease understanding and treatment adherence across multiple therapeutic areas.

Partnerships with academic institutions and key opinion leaders to support early discovery research and translate academic insights into product development.

Collaborative services enabling genomics-informed treatment selection and theranostic guidance for oncology care through external partnerships.

Expertise Areas

  • Branded formulation development and commercialization
  • Critical care therapeutics (anti-infectives and supportive care)
  • Chronic disease management (metabolics: diabetes, hypertension, weight management)
  • Specialty therapeutics (nephrology and urology)
  • Show More (4)

Key Technologies

  • Genomics-based precision oncology and theranostics
  • Drug formulation and dosage form technologies
  • Pharmaceutical supply chain and storage quality systems
  • Clinical education program development

News & Updates

Partnership to expand sepsis and critical care treatment with CytoSorb in India.

Collaboration to launch Enzewhey 98 for critically ill patients.

Excellence in Product Innovation (Micro and Small Enterprise).

Blindwink Awards for Innovative Excellence In Pharmaceutical Sector in the Healthcare & Research Sector category.

Excellence in Healthcare Service Providers – Alternate Medicine.

Emerging company of the year (Pharmaceutical).

View All News

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.